Clinical trial
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
NCT00192673 · Nordic Society for Pediatric Hematology and Oncology, Other · Unknown status
Key facts
| NCT number | NCT00192673 |
|---|---|
| Title | Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses |
| Official title | PEG-asparaginase During Two Treatment Courses in the Treatment of Childhood Acute Lymphoblastic Leukemia |
| Lead sponsor | Nordic Society for Pediatric Hematology and Oncology, Other |
| Collaborators | Medac, Hamburg, Germany Danish Child Cancer Foundation |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | PEG-asparaginase |
| Enrollment | 85 |
| Start date | Jun 1, 2005 |
| Completion | Dec 1, 2013 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 30, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: